Press release
Steady Expansion Forecast for AI In Clinical Trials Market, Projected to Reach $38.21 Billion by 2029
AI In Clinical Trials
AI In Clinical Trials Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent years, the size of the AI in clinical trials market has experienced a rapid expansion. Expectations are for the market to increase from $6.57 billion in 2024 to $9.16 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 39.5%. Factors contributing to the surge during the historic period include healthcare data accumulation, advancements in computing power, endorsement from the FDA for AI, the popularity of wearable devices, and the development of early-stage AI algorithms.
AI In Clinical Trials Market Size Forecast: What's the Projected Valuation by 2029?
The market size for AI in clinical trials is projected to witness immense growth in the coming years. The anticipated market value is $38.21 billion by 2029, with a compound annual growth rate (CAGR) of 42.9%. This growth can be linked to several factors such as the integration of real-world data, AI-enhanced patient enlistment, AI-propelled biomarker identification, and AI-aided trial design optimization, among others. The forecast period is set to experience multiple trends including collaborative learning approaches in AI, AI's application in adaptive trials, AI-assisted outcome forecasting, AI facilitated drug development and AI-enabled drug repurposing.
View the full report here:
https://www.thebusinessresearchcompany.com/report/ai-in-clinical-trials-global-market-report
What Are the Drivers Transforming the AI In Clinical Trials Market?
The surge in chronic and infectious disease instances is anticipated to invigorate the expansion of the AI in clinical trials market. Chronic diseases, which are illnesses persisting for three months or more and deteriorate over time, are often treated with drugs developed through AI in clinical trials. For instance, the Macmillan Cancer Support, a UK-based cancer charity, reported in June 2022 that the population of individuals living with cancer had reached 3 million in 2022, and is forecasted to approach nearly 3.5 million by 2025 and 4 million by 2030 in the UK. Moreover, the UK Health Security Agency, an established UK executive agency, revealed in August 2024 that there had been 368 cases of measles in 2023 in England, indicating an almost sevenfold surge from the 53 instances documented in 2022. The two regions contributing most to these cases were the West Midlands and London, representing 44% and 33% respectively. Thus, the inflating rates of chronic and infectious diseases are fuelling the advancement of the AI in clinical trials market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11961&type=smp
What Long-Term Trends Will Define the Future of the AI In Clinical Trials Market?
The AI in clinical trials market is witnessing an accelerating trend of technological innovations. To stay competitive in the market, companies are increasingly leveraging advanced technologies. As an example, Lantern Pharma, an American clinical-stage oncology firm, unveiled its revolutionary RADR AI and ML platform in February 2023. This platform aims to transform the cost, speed, and duration of oncology drug discovery and development. The future developments of RADR will focus on integrating sophisticated AI and ML techniques to develop antibody-drug conjugates (ADCs). These are highly specific antibodies used in cancer treatment that are linked to potent anti-tumor small molecules.
Which Segments in the AI In Clinical Trials Market Offer the Most Profit Potential?
The ai in clinical trialsmarket covered in this report is segmented -
1) By Offering: Software, Services
2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring
3) By Technology: Machine Learning, Deep Learning, Supervised Learning, Other Technologies
4) By Application: Oncology, Neurological Diseases And Condition, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Immunology Diseases, Other Applications
5) By End-User: Pharmaceuticals And Biotechnology Companies, Contract Research Organizations, Other End-Users
Subsegments:
1) By Software: Clinical Trial Management Systems (CTMS), Data Analytics Software, Predictive Analytics Tools, Patient Recruitment And Retention Software, Real-World Evidence Platforms
2) By Services: Consulting Services, Data Management And Analysis Services, Training And Support Services, Regulatory Compliance Services
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=11961&type=smp
Which Firms Dominate the AI In Clinical Trials Market by Market Share and Revenue in 2025?
Major companies operating in the AI in clinical trials market include Intel, The International Business Machines Corporation (IBM), Koninklijke Philips N.V., ConcertAI, Samaa Technologies, Owkin Inc., Numerate, Neuroute, AiCure, Ardigen, Unlearn AI, PathAI, Exscentia, Aitia Infotech Pvt Ltd., Euretos, VeriSIM Life, Envisagenics, NURITAs, BioSymetrics, BioAge Labs Inc, Trials.Ai, Pharmaseal, Caylx, IQVIA
Which Regions Offer the Highest Growth Potential in the AI In Clinical Trials Market?
North America was the largest region in the AI in clinical trials market in 2024. The regions covered in the AI in clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11961
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Steady Expansion Forecast for AI In Clinical Trials Market, Projected to Reach $38.21 Billion by 2029 here
News-ID: 4226753 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Trial
Clinical Trial Investigative Site Network Market Clinical Trial Investigative Si …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trial Investigative Site Network Market - (By Therapeutic Areas (Oncology, Cardiology, CNS, Pain Management, Endocrine, Others), By Phase (Phase I, Phase II, Phase III, Phase IV), By End-use (Sponsor, CRO)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Clinical Trial Investigative Site Network Market…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025?
The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, with…
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019.
Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
…
Clinical Trial Logistics
Clinical Trial Logistics
16th to 17th May 2011, Marriott Regents Park, London, United Kingdom.
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trials…
Clinical Trial Logistics
Announcing SMi's 5th annual…
Clinical Trial Logistics conference
16th and 17th May 2011, Central London, UK
www.smi-online.co.uk/2011logistics-london6.asp
It currently costs just over £500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical…
